Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05713578RecruitingEarly Phase 1
Apantamide plus docetaxel with hormone therapy for advanced prostate cancer
This early-phase trial tests whether adding apantamide to hormone therapy (and possibly adding docetaxel chemotherapy) works better and is safe for men with high-volume spread of prostate cancer. It’s designed for people who have recently started hormone therapy and haven’t shown clear disease worsening yet.
Jinan, ShandongAges 18–90 - NCT06557941Recruiting
Risk factors for breathing tube removal failure in children
This study looks at why some children in the pediatric ICU have trouble coming off the breathing machine (ventilator). If your child is ready to try stopping the ventilator, this trial will help doctors understand what may make that transition safer.
SohagAges 4 weeks–18 years - NCT06405971Recruiting
Metformin for unruptured brain aneurysms
This trial tests whether the diabetes drug metformin can help prevent unruptured aneurysms in the back part of the brain from growing or causing problems. It is for people whose aneurysms show a specific sign on an MRI scan.
Beijing, Beijing MunicipalityAges 18–75 - NCT06876987Recruiting
Mobile app training for peritoneal dialysis patients
This trial tests a mobile app training system to help people on peritoneal dialysis manage their treatment better. If you are doing your own dialysis and are free from current infections, you may be able to join.
TaichungAges 18 years+ - NCT04927338RecruitingPhase 2
Bacopa supplement study for Gulf War illness symptoms
This trial tests whether Bacopa (a herbal supplement) can improve symptoms of Gulf War Illness (GWI). You may be eligible if you served in the Gulf War and still have ongoing, hard-to-explain fatigue and related symptoms.
Davie, FloridaAges 46–78 - NCT07359443RecruitingPhase 1
Chemo plus MRI-guided radiation before esophageal cancer surgery
This trial tests combining chemotherapy (FLOT) with a special type of MRI-guided radiation before surgery for esophageal adenocarcinoma. It aims to improve treatment results for patients with a specific type and stage of the disease.
Utrecht, UtrechtAges 18 years+ - NCT04916613RecruitingPhase 3
ADT plus darolutamide for vulnerable newly metastatic prostate cancer
This trial studies whether adding darolutamide to standard hormone therapy (ADT) helps men with newly diagnosed metastatic prostate cancer who are physically vulnerable. It aims to control the cancer better while checking safety and how well treatment is tolerated in this group.
CharleroiAges 18 years+ - NCT07359066RecruitingPhase 1/Phase 2
SPR1020 for advanced solid tumors with DNA repair defects
This trial tests an experimental drug (SPR1020) for people with advanced solid tumors that have not responded to standard treatments, especially those with BRCA or related gene mutations. The drug is taken by mouth and the study aims to find the right dose and see if it helps shrink tumors.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07358039Recruiting
Recruitment maneuver after suctioning in ICU patients on ventilators
This study is testing whether a breathing maneuver after suctioning helps restore lung volume in intensive care patients who are on a ventilator. It may help improve breathing and recovery.
Toulon, VARAges 18 years+ - NCT05675722RecruitingPhase 1
Vaginal reconstruction implant test for women born without a vagina
This Phase 1 study tests a vaginal implant/reconstruction device for people born with a missing or closed-off vagina. The goal is to check safety and how well the implanted vaginal tissue construct works over follow-up visits.
Winston-Salem, North CarolinaAges 15–45 - NCT06233942RecruitingPhase 1
Testing a new drug for advanced solid tumors
This early-phase trial tests a new drug called BG-C9074, either alone or with other cancer treatments, for people with certain advanced solid tumors that have not responded to standard therapy. The goal is to see if it is safe and effective.
Los Angeles, CaliforniaAges 18 years+ - NCT07357259Recruiting
Delayed pelvic scan with PSMA PET/CT for high-risk prostate cancer
This trial uses a special PET/CT scan with a radioactive tracer (PSMA) to get detailed images of the pelvis in men with high-risk prostate cancer. The goal is to improve cancer staging and detect recurrence more accurately.
Bologna, ItalyAges 30 years+ - NCT05772130Recruiting
Help family members get cancer genetic test results and counseling
This study tests a family-centered way to share cancer genetic testing results with close relatives, so more relatives get genetic counseling and testing. It may help your eligible family members understand their risk and get the right next steps.
Duarte, CaliforniaAges 18 years+ - NCT07356999Recruiting
Seeing and scoliosis: a visual perception study in teens
This study looks at how scoliosis may affect how you see and process visual information. It compares teens with scoliosis to teens without it to better understand any differences.
LyonAges 11–18 - NCT07357051RecruitingPhase 3
Flu treatment study for children ages 2 to 12
This trial tests a new oral medicine (JKN2301) for children with the flu. It aims to see if the medicine is safe and works well to treat flu symptoms like fever and cough.
Guangzhou, GuangdongAges 2–11 - NCT07356453RecruitingPhase 1
Study of PARG inhibitor FORX-428 for advanced solid tumors
This trial tests a new drug called FORX-428, which targets a protein called PARG, in people with advanced solid tumors. It is for patients whose cancer has not responded to prior treatments and who have specific genetic changes, such as BRCA mutations.
Palo Alto, CaliforniaAges 18 years+ - NCT06609928RecruitingPhase 1
CAR T cell therapy for children with relapsed AML that has FOLR1
This trial tests a special immune cell treatment (CAR T cells) that target a protein called FOLR1 found on some AML cells. It is for children aged 6 or younger whose leukemia has come back or not responded to treatment.
Seattle, WashingtonAges Up to 6 years - NCT04892693RecruitingPhase 2
Talazoparib for advanced breast cancer with DNA repair defects
This trial studies talazoparib (a targeted pill) in people with advanced breast cancer whose tumors have problems repairing certain DNA damage. If your tumor has these specific “DNA repair” defects, the medicine may work better and stop the cancer from growing.
SeoulAges 19 years+ - NCT05408117Recruiting
Compare suture types to reduce skin color changes after surgery
This study looks at whether different types of stitches (sutures) can lower the chance of pigment changes—skin color looking lighter or darker—after dermatology surgery. It may help patients who want to reduce the risk of visible skin color changes as their wound heals.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07352891Recruiting
Digital remote management vs. usual care for heart failure
This trial tests whether using a remote monitoring platform to help manage medications improves outcomes in people with heart failure and reduced pumping function. It compares this approach to standard follow-up care.
BeijingAges 18 years+ - NCT07351968RecruitingPhase 1
Study of HRS-2129 for knee osteoarthritis pain
This trial tests an investigational drug, HRS-2129, for people with knee osteoarthritis who have moderate to severe pain. It aims to see if the drug is safe and effective at reducing pain.
Nanjing, JiangsuAges 18–80 - NCT05837780Enrolling by invitation
Different braces techniques for babies with a cleft lip and palate
This trial compares two different techniques for making a molding device (a baby “nasal/cheek shape” support) for newborns with a cleft lip and palate on one side. It may help your baby get a better starting nose and lip shape during early treatment.
MinyaAges 1 week–1 month - NCT05416489Recruiting
Compare two ways to place a bedside tracheostomy
This study compares two methods doctors can use to place a tracheostomy (a breathing tube in the windpipe) at the bedside. It may help find a safer or easier approach for people who need long-term breathing support or cannot be safely weaned from a breathing machine.
Santiago de Compostela, A CoruñaAges 18–85 - NCT06365840RecruitingPhase 2
Study of IMC-001 for advanced tumors with high mutations
This trial tests an experimental drug called IMC-001 for people whose cancer has spread or is locally advanced and has a high number of genetic mutations (TMB-H). The drug aims to help the immune system fight cancer.
GoyangAges 19 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.